CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.3B
1-Year Est. Return 45.88%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$92.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
543
New
Increased
Reduced
Closed

Top Buys

1 +$16.2M
2 +$6.26M
3 +$4.07M
4
META icon
Meta Platforms (Facebook)
META
+$3.94M
5
RACE icon
Ferrari
RACE
+$2.98M

Top Sells

1 +$11.5M
2 +$7.75M
3 +$6.78M
4
ORCL icon
Oracle
ORCL
+$2.75M
5
RCL icon
Royal Caribbean
RCL
+$2.72M

Sector Composition

1 Technology 37.86%
2 Healthcare 22.63%
3 Communication Services 13.04%
4 Consumer Discretionary 10.29%
5 Consumer Staples 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSNL icon
401
Personalis
PSNL
$869M
$115K 0.01%
14,471
-1,073
ZLAB icon
402
Zai Lab
ZLAB
$2.15B
$113K 0.01%
6,380
-2,000
IVVD icon
403
Invivyd
IVVD
$516M
$112K 0.01%
+45,157
LYEL icon
404
Lyell Immunopharma
LYEL
$544M
$106K 0.01%
3,457
+90
CMPS
405
Compass Pathways
CMPS
$845M
$106K 0.01%
15,353
-723
ATEC icon
406
Alphatec Holdings
ATEC
$1.89B
$105K 0.01%
5,000
MGTX icon
407
MeiraGTx Holdings
MGTX
$625M
$104K 0.01%
13,116
-985
IMRX icon
408
Immuneering
IMRX
$363M
$102K 0.01%
15,522
+10,522
PRME icon
409
Prime Medicine
PRME
$731M
$102K 0.01%
29,414
-1,236
KROS icon
410
Keros Therapeutics
KROS
$353M
$101K 0.01%
4,964
-2,155
FULC icon
411
Fulcrum Therapeutics
FULC
$533M
$99.7K 0.01%
+8,819
CGEM icon
412
Cullinan Oncology
CGEM
$881M
$99.6K 0.01%
9,626
-729
AXGN icon
413
Axogen
AXGN
$1.59B
$98.2K 0.01%
+3,000
PACB icon
414
Pacific Biosciences
PACB
$414M
$92K 0.01%
49,196
-3,454
BHVN icon
415
Biohaven
BHVN
$1.36B
$90.3K 0.01%
8,000
-12,000
IRWD icon
416
Ironwood Pharmaceuticals
IRWD
$603M
$89.3K 0.01%
26,508
-1,964
VNDA icon
417
Vanda Pharmaceuticals
VNDA
$565M
$84.9K 0.01%
9,630
-727
PRTA icon
418
Prothena Corp
PRTA
$526M
$83.8K 0.01%
8,772
-664
SLN
419
Silence Therapeutics
SLN
$296M
$83K 0.01%
13,653
+5,421
ZVRA icon
420
Zevra Therapeutics
ZVRA
$623M
$82.2K 0.01%
9,174
-666
LENZ
421
LENZ Therapeutics
LENZ
$374M
$81.6K 0.01%
5,099
-2,900
BLTE
422
Belite Bio
BLTE
$6.53B
$80K 0.01%
500
-4,500
BIOA
423
BioAge Labs
BIOA
$876M
$77.3K 0.01%
+5,843
GLPG icon
424
Galapagos
GLPG
$2.19B
$77K 0.01%
2,356
-155
MRVI icon
425
Maravai LifeSciences
MRVI
$512M
$76.8K 0.01%
23,631
-1,729